Modalis Therapeutics Corporation Financial Overview
Modalis Therapeutics Corporation's market cap is currently ¥4.62B. The company's EPS TTM is ¥-10.13; its P/E ratio is -2.03; Modalis Therapeutics Corporation is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
